Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $198M (100.0% shares, 0.0% debt)

Holdings (39)

ZBH ZIMMER BIOMET HLDGS INC 9.8%
Value $19.38M Shares 164,619 Est. Cost $109.74 Unrealized +1.1%
BMY BRISTOL MYERS SQUIBB CO 9.4%
Value $18.62M Shares 410,490 Est. Cost $37.62 Unrealized -4.0%
KURA KURA ONCOLOGY INC 8.6%
Value $17.09M Shares 867,810 Est. Cost $16.52 Unrealized +0.5%
REATA PHARMACEUTICALS INC 5.9%
Value $11.79M Shares 124,965 Est. Cost $46.26 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.9%
Value $9.808M Shares 400,000 Est. Cost $11.58 Unrealized +30.1%
ARENA PHARMACEUTICALS INC 4.9%
Value $9.633M Shares 164,300 Est. Cost $42.17 Unrealized
HANGER INC 4.7%
Value $9.416M Shares 491,685 Est. Cost $20.83 Unrealized
QURE UNIQURE NV 4.7%
Value $9.378M Shares 120,000 Est. Cost $63.72 Unrealized 0.0%
URGN UROGEN PHARMA LTD 4.7%
Value $9.378M Shares 260,928 Est. Cost $39.93 Unrealized -7.7%
ALBIREO PHARMA INC 4.1%
Value $8.167M Shares 253,327 Est. Cost $29.61 Unrealized
STRONGBRIDGE BIOPHARMA PLC 4.0%
Value $7.972M Shares 2,546,997 Est. Cost $3.69 Unrealized
HOMOLOGY MEDICINES INC 3.6%
Value $7.222M Shares 369,048 Est. Cost $19.57 Unrealized
CLOVIS ONCOLOGY INC 3.4%
Value $6.692M Shares 450,000 Est. Cost $19.47 Unrealized
CNC CENTENE CORP DEL 3.3%
Value $6.634M Shares 126,500 Est. Cost $57.97 Unrealized -6.8%
CI CIGNA CORP NEW 2.5%
Value $4.92M Shares 31,227 Est. Cost $179.63 Unrealized -20.2%
BMRN BIOMARIN PHARMACEUTICAL INC 2.2%
Value $4.385M Shares 51,200 Est. Cost $91.65 Unrealized -6.7%
ALDX ALDEYRA THERAPEUTICS INC 2.1%
Value $4.188M Shares 697,921 Est. Cost $9.35 Unrealized -19.5%
CATALYST BIOSCIENCES INC 2.0%
Value $4.032M Shares 547,092 Est. Cost $9.09 Unrealized
INTEC PHARMA LTD JERUSALEM 1.8%
Value $3.541M Shares 815,789 Est. Cost $4.51 Unrealized
ACIU AC IMMUNE SA 1.6%
Value $3.13M Shares 563,900 Est. Cost $6.36 Unrealized -19.9%
ASSEMBLY BIOSCIENCES INC 1.4%
Value $2.698M Shares 200,000 Est. Cost $28.21 Unrealized
TELIGENT INC NEW 0.9%
Value $1.87M Shares 2,967,721 Est. Cost $3.21 Unrealized
WELLCARE HEALTH PLANS INC 0.9%
Value $1.853M Shares 6,500 Est. Cost $236.10 Unrealized
ASGN ASGN INC 0.9%
Value $1.818M Shares 30,000 Est. Cost $64.66 Unrealized -7.1%
EXACT SCIENCES CORP 0.8%
Value $1.664M Shares 14,100 Est. Cost Unrealized
MOLECULAR TEMPLATES INC 0.8%
Value $1.651M Shares 197,681 Est. Cost $5.81 Unrealized
EOLS EVOLUS INC 0.8%
Value $1.646M Shares 112,590 Est. Cost $19.82 Unrealized 0.0%
PSNL PERSONALIS INC 0.8%
Value $1.533M Shares 56,446 Est. Cost $28.28 Unrealized 0.0%
SIERRA ONCOLOGY INC 0.8%
Value $1.502M Shares 2,681,618 Est. Cost $1.83 Unrealized
UROV UROVANT SCIENCES LTD 0.6%
Value $1.128M Shares 142,620 Est. Cost $9.41 Unrealized
ARQULE INC 0.5%
Value $921K Shares 83,675 Est. Cost $11.01 Unrealized
MILLENDO THERAPEUTICS INC 0.4%
Value $854K Shares 73,868 Est. Cost $8.31 Unrealized
PROVIDENCE SVC CORP 0.4%
Value $842K Shares 14,677 Est. Cost $67.28 Unrealized
ADMA ADMA BIOLOGICS INC 0.4%
Value $719K Shares 185,721 Est. Cost $4.41 Unrealized 0.0%
NEVRO CORP 0.4%
Value $713K Shares 11,000 Est. Cost $62.51 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 0.3%
Value $671K Shares 8,600 Est. Cost $93.51 Unrealized 0.0%
CIDARA THERAPEUTICS INC 0.3%
Value $603K Shares 358,963 Est. Cost $4.82 Unrealized
KEZAR LIFE SCIENCES INC 0.1%
Value $264K Shares 34,224 Est. Cost $7.71 Unrealized
AQUINOX PHARMACEUTICALS INC 0.0%
Value $9,000 Shares 3,637 Est. Cost $2.50 Unrealized